The present invention provides a compound of general formula (I) (wherein, R1, X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
-
Paragraph 1563; 1564; 1567; 1568
(2018/06/23)
ESTRATRIENE DERIVATIVES
Compounds and methods for modulating mesenchymal cell function, for instance smooth muscle and fibroblast proliferation or cytokine expression, and for treating conditions associated with mesenchymal cell function, for instance airway hyperresponsiveness
-
Page 67
(2008/06/13)
More Articles about upstream products of 16115-54-1